Leticia Montoya-Garcia
Leeds, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
A multivariable prediction model to identify anti-CCP positive people in those with non-specific musculoskeletal symptoms in primary care.
Journal: Rheumatology (Oxford, England)
Published: September 13, 2024
Factors associated with resolution of ultrasound subclinical synovitis in anti-CCP-positive individuals with musculoskeletal symptoms: a UK prospective cohort study.
Journal: The Lancet. Rheumatology
Published: August 31, 2023
Predicting Inflammatory Arthritis in At-Risk Persons: Development of Scores for Risk Stratification.
Predicting Inflammatory Arthritis in At-Risk Persons: Development of Scores for Risk Stratification.
Journal: Annals of internal medicine
Published: July 31, 2023
Ultrasound in anti-CCP+ at-risk individuals without clinical synovitis: development of a novel 6-joint protocol for feasible risk prediction.
Journal: Rheumatology (Oxford, England)
Published: July 20, 2023
Disease modification in ankylosing spondylitis with TNF inhibitors: spotlight on early phase clinical trials.
Journal: Expert opinion on investigational drugs
Published: November 29, 2021
Ultrasound subclinical synovitis in anti-CCP-positive at-risk individuals with musculoskeletal symptoms: an important and predictable stage in the rheumatoid arthritis continuum.
Journal: Rheumatology (Oxford, England)
Published: July 28, 2021
Prioritising referrals of individuals at-risk of RA: guidance based on results of a 10-year national primary care observational study.
Journal: Arthritis research & therapy
Published: July 25, 2021
Ultrasound shows swollen joints are the better proxy for synovitis than tender joints in DMARD-naïve early psoriatic arthritis.
Journal: Rheumatology advances in practice
Published: July 14, 2021
Dactylitis is an indicator of a more severe phenotype independently associated with greater SJC, CRP, ultrasound synovitis and erosive damage in DMARD-naive early psoriatic arthritis.
Journal: Annals of the rheumatic diseases
Published: June 14, 2021
Real-world experience of effectiveness of non-medical switch from originator to biosimilar rituximab in rheumatoid arthritis.
Journal: Rheumatology (Oxford, England)
Published: August 17, 2020
Last Updated: 09/26/2026